Skip to main content
Top
Published in: European Radiology 2/2018

01-02-2018 | Breast

Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI

Authors: Yuhao Dong, Qianjin Feng, Wei Yang, Zixiao Lu, Chunyan Deng, Lu Zhang, Zhouyang Lian, Jing Liu, Xiaoning Luo, Shufang Pei, Xiaokai Mo, Wenhui Huang, Changhong Liang, Bin Zhang, Shuixing Zhang

Published in: European Radiology | Issue 2/2018

Login to get access

Abstract

Objectives

To predict sentinel lymph node (SLN) metastasis in breast cancer patients using radiomics based on T2-weighted fat suppression (T2-FS) and diffusion-weighted MRI (DWI).

Methods

We enrolled 146 patients with histologically proven breast cancer. All underwent pretreatment T2-FS and DWI MRI scan. In all, 10,962 texture and four non-texture features were extracted for each patient. The 0.623 + bootstrap method and the area under the curve (AUC) were used to select the features. We constructed ten logistic regression models (orders of 1–10) based on different combination of image features using stepwise forward method.

Results

For T2-FS, model 10 with ten features yielded the highest AUC of 0.847 in the training set and 0.770 in the validation set. For DWI, model 8 with eight features reached the highest AUC of 0.847 in the training set and 0.787 in the validation set. For joint T2-FS and DWI, model 10 with ten features yielded an AUC of 0.863 in the training set and 0.805 in the validation set.

Conclusions

Full utilisation of breast cancer-specific textural features extracted from anatomical and functional MRI images improves the performance of radiomics in predicting SLN metastasis, providing a non-invasive approach in clinical practice.

Key Points

SLN biopsy to access breast cancer metastasis has multiple complications.
• Radiomics uses features extracted from medical images to characterise intratumour heterogeneity.
• We combined T 2 -FS and DWI textural features to predict SLN metastasis non-invasively.
Appendix
Available only for authorised users
Literature
1.
go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed
2.
go back to reference Qiu PF, Liu JJ, Wang YS, Yang GR, Liu YB, Sun X et al (2012) Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients. Jpn J Clin Oncol 42:1002–1007CrossRefPubMed Qiu PF, Liu JJ, Wang YS, Yang GR, Liu YB, Sun X et al (2012) Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients. Jpn J Clin Oncol 42:1002–1007CrossRefPubMed
3.
go back to reference Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553CrossRefPubMed Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553CrossRefPubMed
4.
go back to reference Lyman GH, Giuliano AE, Somerfield MR, Benson AR, Bodurka DC, Burstein HJ et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720CrossRefPubMed Lyman GH, Giuliano AE, Somerfield MR, Benson AR, Bodurka DC, Burstein HJ et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720CrossRefPubMed
5.
go back to reference Kootstra J, Hoekstra-Weebers JE, Rietman H, de Vries J, Baas P, Geertzen JH et al (2008) Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol 15:2533–2541CrossRefPubMedPubMedCentral Kootstra J, Hoekstra-Weebers JE, Rietman H, de Vries J, Baas P, Geertzen JH et al (2008) Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol 15:2533–2541CrossRefPubMedPubMedCentral
6.
go back to reference Chen JY, Chen JJ, Yang BL, Liu ZB, Huang XY, Liu GY et al (2012) Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram. Breast Cancer Res Treat 135:839–848CrossRefPubMed Chen JY, Chen JJ, Yang BL, Liu ZB, Huang XY, Liu GY et al (2012) Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram. Breast Cancer Res Treat 135:839–848CrossRefPubMed
7.
go back to reference Nottegar A, Veronese N, Senthil M, Roumen RM, Stubbs B, Choi AH et al (2016) Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis. Eur J Surg Oncol 42:919–925CrossRefPubMed Nottegar A, Veronese N, Senthil M, Roumen RM, Stubbs B, Choi AH et al (2016) Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis. Eur J Surg Oncol 42:919–925CrossRefPubMed
8.
go back to reference La Verde N, Biagioli E, Gerardi C, Cordovana A, Casiraghi C, Floriani I et al (2016) Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study. Springerplus 5:114CrossRefPubMedPubMedCentral La Verde N, Biagioli E, Gerardi C, Cordovana A, Casiraghi C, Floriani I et al (2016) Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study. Springerplus 5:114CrossRefPubMedPubMedCentral
9.
go back to reference Viale G, Zurrida S, Maiorano E, Mazzarol G, Pruneri G, Paganelli G et al (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103:492–500CrossRefPubMed Viale G, Zurrida S, Maiorano E, Mazzarol G, Pruneri G, Paganelli G et al (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103:492–500CrossRefPubMed
10.
go back to reference Ozemir IA, Orhun K, Eren T, Baysal H, Sagiroglu J, Leblebici M et al (2016) Factors affecting sentinel lymph node metastasis in Turkish breast cancer patients: Predictive value of Ki-67 and the size of lymph node. Bratisl Lek Listy 117:436–441PubMed Ozemir IA, Orhun K, Eren T, Baysal H, Sagiroglu J, Leblebici M et al (2016) Factors affecting sentinel lymph node metastasis in Turkish breast cancer patients: Predictive value of Ki-67 and the size of lymph node. Bratisl Lek Listy 117:436–441PubMed
11.
go back to reference Matsuzawa F, Omoto K, Einama T, Abe H, Suzuki T, Hamaguchi J et al (2015) Accurate evaluation of axillary sentinel lymph node metastasis using contrast-enhanced ultrasonography with Sonazoid in breast cancer: a preliminary clinical trial. Springerplus 4:509CrossRefPubMedPubMedCentral Matsuzawa F, Omoto K, Einama T, Abe H, Suzuki T, Hamaguchi J et al (2015) Accurate evaluation of axillary sentinel lymph node metastasis using contrast-enhanced ultrasonography with Sonazoid in breast cancer: a preliminary clinical trial. Springerplus 4:509CrossRefPubMedPubMedCentral
12.
go back to reference Omoto K, Matsunaga H, Take N, Hozumi Y, Takehara M, Omoto Y et al (2009) Sentinel node detection method using contrast-enhanced ultrasonography with sonazoid in breast cancer: preliminary clinical study. Ultrasound Med Biol 35:1249–1256CrossRefPubMed Omoto K, Matsunaga H, Take N, Hozumi Y, Takehara M, Omoto Y et al (2009) Sentinel node detection method using contrast-enhanced ultrasonography with sonazoid in breast cancer: preliminary clinical study. Ultrasound Med Biol 35:1249–1256CrossRefPubMed
13.
go back to reference Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006PubMedPubMedCentral Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006PubMedPubMedCentral
14.
go back to reference Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed
15.
go back to reference Kickingereder P, Gotz M, Muschelli J, Wick A, Neuberger U, Shinohara RT et al (2016) Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin Cancer Res 22:5765–5771CrossRefPubMedPubMedCentral Kickingereder P, Gotz M, Muschelli J, Wick A, Neuberger U, Shinohara RT et al (2016) Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin Cancer Res 22:5765–5771CrossRefPubMedPubMedCentral
16.
go back to reference Li H, Zhu Y, Burnside ES, Drukker K, Hoadley KA, Fan C et al (2016) MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays. Radiology 281:382–391CrossRefPubMedPubMedCentral Li H, Zhu Y, Burnside ES, Drukker K, Hoadley KA, Fan C et al (2016) MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays. Radiology 281:382–391CrossRefPubMedPubMedCentral
17.
go back to reference Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z et al (2016) Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281:947–957CrossRefPubMed Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z et al (2016) Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281:947–957CrossRefPubMed
18.
go back to reference Prasanna P, Patel J, Partovi S, Madabhushi A, Tiwari P (2016) Radiomic features from the peritumoral brain parenchyma on treatment-naive multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: preliminary findings. Eur Radiol. doi:10.1007/s00330-016-4637-3 PubMed Prasanna P, Patel J, Partovi S, Madabhushi A, Tiwari P (2016) Radiomic features from the peritumoral brain parenchyma on treatment-naive multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: preliminary findings. Eur Radiol. doi:10.​1007/​s00330-016-4637-3 PubMed
19.
go back to reference Aerts HJ, Grossmann P, Tan Y, Oxnard GG, Rizvi N, Schwartz LH et al (2016) Defining a radiomic response phenotype: a pilot study using targeted therapy in NSCLC. Sci Rep 6:33860CrossRefPubMedPubMedCentral Aerts HJ, Grossmann P, Tan Y, Oxnard GG, Rizvi N, Schwartz LH et al (2016) Defining a radiomic response phenotype: a pilot study using targeted therapy in NSCLC. Sci Rep 6:33860CrossRefPubMedPubMedCentral
20.
go back to reference Gnep K, Fargeas A, Gutierrez-Carvajal RE, Commandeur F, Mathieu R, Ospina JD et al (2017) Haralick textural features on T2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging 45:103–117CrossRefPubMed Gnep K, Fargeas A, Gutierrez-Carvajal RE, Commandeur F, Mathieu R, Ospina JD et al (2017) Haralick textural features on T2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging 45:103–117CrossRefPubMed
21.
go back to reference Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed
22.
go back to reference Reshef DN, Reshef YA, Finucane HK, Grossman SR, McVean G, Turnbaugh PJ et al (2011) Detecting novel associations in large data sets. Science 334:1518–1524CrossRefPubMedPubMedCentral Reshef DN, Reshef YA, Finucane HK, Grossman SR, McVean G, Turnbaugh PJ et al (2011) Detecting novel associations in large data sets. Science 334:1518–1524CrossRefPubMedPubMedCentral
23.
go back to reference Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663CrossRefPubMed Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663CrossRefPubMed
24.
go back to reference Toshikawa C, Koyama Y, Nagahashi M, Tatsuda K, Moro K, Tsuchida J et al (2015) Predictive factors for non-sentinel lymph node metastasis in the case of positive sentinel lymph node metastasis in two or fewer nodes in breast cancer. J Clin Med Res 7:620–626CrossRefPubMedPubMedCentral Toshikawa C, Koyama Y, Nagahashi M, Tatsuda K, Moro K, Tsuchida J et al (2015) Predictive factors for non-sentinel lymph node metastasis in the case of positive sentinel lymph node metastasis in two or fewer nodes in breast cancer. J Clin Med Res 7:620–626CrossRefPubMedPubMedCentral
25.
go back to reference Olson JA, McCall LM, Beitsch P, Whitworth PW et al (2008) Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from the American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 26:3530–3535CrossRefPubMed Olson JA, McCall LM, Beitsch P, Whitworth PW et al (2008) Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from the American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 26:3530–3535CrossRefPubMed
26.
go back to reference Yeniay L, Carti E, Karaca C, Zekioglu O, Yararbas U, Yilmaz R et al (2012) A new and simple predictive formula for non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes, and validation of 3 different nomograms in Turkish breast cancer patients. Breast Care (Basel) 7:397–402CrossRef Yeniay L, Carti E, Karaca C, Zekioglu O, Yararbas U, Yilmaz R et al (2012) A new and simple predictive formula for non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes, and validation of 3 different nomograms in Turkish breast cancer patients. Breast Care (Basel) 7:397–402CrossRef
27.
go back to reference Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y et al (2015) Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients. Onco Targets Ther 8:487–493PubMedPubMedCentral Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y et al (2015) Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients. Onco Targets Ther 8:487–493PubMedPubMedCentral
28.
go back to reference Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D (2009) Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population. Ann Surg Oncol 16:1136–1142CrossRefPubMed Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D (2009) Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population. Ann Surg Oncol 16:1136–1142CrossRefPubMed
29.
go back to reference Zhu L, Jin L, Li S, Chen K, Jia W, Shan Q et al (2013) Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis. Breast Cancer Res Treat 137:783–795CrossRefPubMed Zhu L, Jin L, Li S, Chen K, Jia W, Shan Q et al (2013) Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis. Breast Cancer Res Treat 137:783–795CrossRefPubMed
30.
go back to reference Fujii T, Yajima R, Tatsuki H, Suto T, Morita H, Tsutsumi S et al (2015) Significance of lymphatic invasion combined with size of primary tumor for predicting sentinel lymph node metastasis in patients with breast cancer. Anticancer Res 35:3581–3584PubMed Fujii T, Yajima R, Tatsuki H, Suto T, Morita H, Tsutsumi S et al (2015) Significance of lymphatic invasion combined with size of primary tumor for predicting sentinel lymph node metastasis in patients with breast cancer. Anticancer Res 35:3581–3584PubMed
31.
go back to reference Nie K, Shi L, Chen Q, Hu X, Jabbour SK, Yue N et al (2016) Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res 22:5256–5264CrossRefPubMed Nie K, Shi L, Chen Q, Hu X, Jabbour SK, Yue N et al (2016) Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res 22:5256–5264CrossRefPubMed
32.
go back to reference Gladwish A, Milosevic M, Fyles A, Xie J, Halankar J, Metser U et al (2016) Association of apparent diffusion coefficient with disease recurrence in patients with locally advanced cervical cancer treated with radical chemotherapy and radiation therapy. Radiology 279:158–166CrossRefPubMed Gladwish A, Milosevic M, Fyles A, Xie J, Halankar J, Metser U et al (2016) Association of apparent diffusion coefficient with disease recurrence in patients with locally advanced cervical cancer treated with radical chemotherapy and radiation therapy. Radiology 279:158–166CrossRefPubMed
33.
go back to reference Ryoo SM, Jeon SB, Sohn CH, Ahn S, Han C, Lee BK et al (2015) Predicting outcome with diffusion-weighted imaging in cardiac arrest patients receiving hypothermia therapy: multicenter retrospective cohort study. Crit Care Med 43:2370–2377CrossRefPubMed Ryoo SM, Jeon SB, Sohn CH, Ahn S, Han C, Lee BK et al (2015) Predicting outcome with diffusion-weighted imaging in cardiac arrest patients receiving hypothermia therapy: multicenter retrospective cohort study. Crit Care Med 43:2370–2377CrossRefPubMed
34.
go back to reference Giganti F, Orsenigo E, Esposito A, Chiari D, Salerno A, Ambrosi A et al (2015) Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer. Radiology 276:444–452CrossRefPubMed Giganti F, Orsenigo E, Esposito A, Chiari D, Salerno A, Ambrosi A et al (2015) Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer. Radiology 276:444–452CrossRefPubMed
35.
go back to reference Schipper RJ, Paiman ML, Beets-Tan RG, Nelemans PJ, de Vries B, Heuts EM et al (2015) Diagnostic performance of dedicated axillary T2- and diffusion-weighted MR imaging for nodal staging in breast cancer. Radiology 275:345–355CrossRefPubMed Schipper RJ, Paiman ML, Beets-Tan RG, Nelemans PJ, de Vries B, Heuts EM et al (2015) Diagnostic performance of dedicated axillary T2- and diffusion-weighted MR imaging for nodal staging in breast cancer. Radiology 275:345–355CrossRefPubMed
36.
go back to reference Yoon HJ, Kim Y, Kim BS (2015) Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ. Eur Radiol 25:3648–3658CrossRefPubMed Yoon HJ, Kim Y, Kim BS (2015) Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ. Eur Radiol 25:3648–3658CrossRefPubMed
37.
go back to reference Mori N, Ota H, Mugikura S, Takasawa C, Tominaga J, Ishida T et al (2013) Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters. Eur Radiol 23:2705–2712CrossRefPubMed Mori N, Ota H, Mugikura S, Takasawa C, Tominaga J, Ishida T et al (2013) Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters. Eur Radiol 23:2705–2712CrossRefPubMed
Metadata
Title
Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI
Authors
Yuhao Dong
Qianjin Feng
Wei Yang
Zixiao Lu
Chunyan Deng
Lu Zhang
Zhouyang Lian
Jing Liu
Xiaoning Luo
Shufang Pei
Xiaokai Mo
Wenhui Huang
Changhong Liang
Bin Zhang
Shuixing Zhang
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 2/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5005-7

Other articles of this Issue 2/2018

European Radiology 2/2018 Go to the issue